title: Microalbuminuria, another use for paricalcitol? Our experience in advanced chronic kidney disease.
authors.forename: Raquel
authors.initials: R
authors.lastname: Blanco-García
authors.forename: Juan J
authors.initials: JJ
authors.lastname: Bravo-López
authors.forename: Mercedes
authors.initials: M
authors.lastname: Moreiras-Plaza
authors.forename: Walfred
authors.initials: W
authors.lastname: Nájera-de la Garza
authors.forename: Cynthia
authors.initials: C
authors.lastname: Cossio-Annibar
authors.forename: Laura
authors.initials: L
authors.lastname: Beato-Coo
authors.forename: Gloria
authors.initials: G
authors.lastname: Rodríguez-Goyanes
mesh_terms: D000419:Albuminuria / Q000097:blood / Q000188:drug therapy*; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002112:Calcifediol / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D004359:Drug Therapy, Combination; D004872:Ergocalciferols / Q000008:administration & dosage / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000097:blood / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000097:blood / Q000188:drug therapy* / Q000628:therapy / Q000652:urine; D010281:Parathyroid Hormone / Q000097:blood; D010758:Phosphorus / Q000097:blood; D006435:Renal Dialysis / Q000009:adverse effects
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004872:Ergocalciferols; D010281:Parathyroid Hormone; D010758:Phosphorus; C084656:paricalcitol; D002112:Calcifediol; D002118:Calcium